ModelEdge

Actinium Pharmaceuticals Inc.
ATNM
Filing TypeS-3
Filing Date8/10/2023
Updated8/11/23, 3:00 AM

Filing

S-3
Earnings Release

Exhibits

S-3Registration Statement for Securities Offered under a Shelf Registration
EX-5.1OPINION OF HAYNES AND BOONE LLP
EX-23.1CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEESFILING FEE TABLE
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic